$27.08
+0.35
(+1.31%)▲
Insights on Chemours Company, The
Revenue is down for the last 3 quarters, 1.64B → 1.36B (in $), with an average decrease of 9.0% per quarter
Netprofit is down for the last 2 quarters, 20.0M → -26.0M (in $), with an average decrease of 230.0% per quarter
In the last 1 year, Ecolab Inc. has given 34.4% return, outperforming this stock by 36.2%
In the last 3 years, Chemours Company, The has experienced a drawdown of -9.7%, however Linde Plc resisted the overall trend and outperformed by 7.1%
1.48%
Downside
Day's Volatility :2.77%
Upside
1.31%
44.24%
Downside
52 Weeks Volatility :60.33%
Upside
28.85%
Period | Chemours Company, The | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -14.55% | 7.1% | 0.0% |
6 Months | 14.7% | 18.6% | 0.0% |
1 Year | -1.78% | 11.1% | 1.3% |
3 Years | -13.45% | 6.5% | -22.1% |
Market Capitalization | 4.0B |
Book Value | $4.96 |
Dividend Share | 1.0 |
Dividend Yield | 3.74% |
Earnings Per Share (EPS) | -1.6 |
PEG Ratio | 1.67 |
Wall Street Target Price | 31.44 |
Profit Margin | -3.95% |
Operating Margin TTM | 6.54% |
Return On Assets TTM | 5.29% |
Return On Equity TTM | -25.68% |
Revenue TTM | 6.0B |
Revenue Per Share TTM | 40.47 |
Quarterly Revenue Growth YOY | 1.7000000000000002% |
Gross Profit TTM | 1.6B |
EBITDA | 980.0M |
Diluted Eps TTM | -1.6 |
Quarterly Earnings Growth YOY | -0.91 |
EPS Estimate Current Year | 2.26 |
EPS Estimate Next Year | 3.77 |
EPS Estimate Current Quarter | 0.25 |
EPS Estimate Next Quarter | 0.85 |
What analysts predicted
Upside of 16.1%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 6.6B | ↑ 7.36% |
Net Income | 995.0M | ↑ 33.38% |
Net Profit Margin | 14.99% | ↑ 2.92% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 5.5B | ↓ 16.75% |
Net Income | -52.0M | ↓ 105.23% |
Net Profit Margin | -0.94% | ↓ 15.93% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 5.0B | ↓ 10.08% |
Net Income | 219.0M | ↓ 521.15% |
Net Profit Margin | 4.41% | ↑ 5.35% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 6.3B | ↑ 27.69% |
Net Income | 608.0M | ↑ 177.63% |
Net Profit Margin | 9.58% | ↑ 5.17% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 6.8B | ↑ 7.08% |
Net Income | 578.0M | ↓ 4.93% |
Net Profit Margin | 8.51% | ↓ 1.07% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.0B | ↓ 11.29% |
Net Income | -238.0M | ↓ 141.18% |
Net Profit Margin | -3.95% | ↓ 12.46% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.8B | ↓ 7.21% |
Net Income | 240.0M | ↑ 19.4% |
Net Profit Margin | 13.51% | ↑ 3.01% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.3B | ↓ 24.7% |
Net Income | -97.0M | ↓ 140.42% |
Net Profit Margin | -7.25% | ↓ 20.76% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↑ 14.8% |
Net Income | 145.0M | ↓ 249.48% |
Net Profit Margin | 9.44% | ↑ 16.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↑ 6.97% |
Net Income | -376.0M | ↓ 359.31% |
Net Profit Margin | -22.88% | ↓ 32.32% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↓ 9.49% |
Net Income | 20.0M | ↓ 105.32% |
Net Profit Margin | 1.34% | ↑ 24.22% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4B | ↓ 8.47% |
Net Income | -26.0M | ↓ 230.0% |
Net Profit Margin | -1.91% | ↓ 3.25% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 7.4B | ↑ 0.95% |
Total Liabilities | 6.3B | ↓ 1.34% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 7.3B | ↓ 1.41% |
Total Liabilities | 6.6B | ↑ 3.48% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 7.1B | ↓ 2.42% |
Total Liabilities | 6.3B | ↓ 4.51% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 7.6B | ↑ 6.61% |
Total Liabilities | 6.5B | ↑ 3.21% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 7.6B | ↑ 1.19% |
Total Liabilities | 6.5B | ↑ 1.0% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 8.3B | ↑ 8.0% |
Total Liabilities | 7.5B | ↑ 14.99% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 7.7B | ↑ 0.19% |
Total Liabilities | 6.5B | ↓ 0.84% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 7.6B | ↓ 1.36% |
Total Liabilities | 6.5B | ↑ 1.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.6B | ↓ 0.21% |
Total Liabilities | 6.4B | ↓ 2.1% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.7B | ↑ 0.47% |
Total Liabilities | 6.9B | ↑ 7.1% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.9B | ↑ 3.76% |
Total Liabilities | 7.2B | ↑ 4.98% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 8.3B | ↑ 3.81% |
Total Liabilities | 7.5B | ↑ 4.46% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.1B | ↑ 78.4% |
Investing Cash Flow | -487.0M | ↑ 31.62% |
Financing Cash Flow | -993.0M | ↓ 381.3% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 650.0M | ↓ 42.98% |
Investing Cash Flow | -483.0M | ↓ 0.82% |
Financing Cash Flow | -419.0M | ↓ 57.8% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 807.0M | ↑ 24.15% |
Investing Cash Flow | -234.0M | ↓ 51.55% |
Financing Cash Flow | -449.0M | ↑ 7.16% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 820.0M | ↑ 1.61% |
Investing Cash Flow | 220.0M | ↓ 194.02% |
Financing Cash Flow | -560.0M | ↑ 24.72% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 754.0M | ↓ 8.05% |
Investing Cash Flow | -284.0M | ↓ 229.09% |
Financing Cash Flow | -685.0M | ↑ 22.32% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 301.0M | ↑ 3.44% |
Investing Cash Flow | -74.0M | ↑ 111.43% |
Financing Cash Flow | -175.0M | ↑ 33.59% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 160.0M | ↓ 46.84% |
Investing Cash Flow | -65.0M | ↓ 12.16% |
Financing Cash Flow | -190.0M | ↑ 8.57% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -119.0M | ↓ 174.37% |
Investing Cash Flow | -97.0M | ↑ 49.23% |
Financing Cash Flow | -73.0M | ↓ 61.58% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 61.0M | ↓ 151.26% |
Investing Cash Flow | -60.0M | ↓ 38.14% |
Financing Cash Flow | -73.0M | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 130.0M | ↑ 113.11% |
Investing Cash Flow | -99.0M | ↑ 65.0% |
Financing Cash Flow | 325.0M | ↓ 545.21% |
Sell
Neutral
Buy
Chemours Company, The is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Chemours Company, The | -4.55% | 14.7% | -1.78% | -13.45% | -28.91% |
Air Products & Chemicals Inc. | -1.21% | -14.5% | -19.06% | -19.13% | 17.58% |
Lyondellbasell Industries N.v. | 0.29% | 12.93% | 10.75% | -3.96% | 13.67% |
Linde Plc | -4.84% | 21.94% | 21.05% | 53.47% | 152.05% |
Sherwin-williams Company, The | -11.19% | 27.29% | 29.36% | 12.68% | 101.9% |
Ecolab Inc. | -2.77% | 39.14% | 34.38% | -2.66% | 20.39% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Chemours Company, The | 10.03 | NA | 1.67 | 2.26 | -0.26 | 0.05 | 0.04 | 4.96 |
Air Products & Chemicals Inc. | 22.41 | 22.41 | 1.37 | 12.32 | 0.15 | 0.05 | 0.03 | 66.91 |
Lyondellbasell Industries N.v. | 15.52 | 15.52 | 1.8 | 8.26 | 0.16 | 0.06 | 0.05 | 39.85 |
Linde Plc | 35.32 | 35.32 | 2.65 | 15.51 | 0.15 | 0.06 | 0.01 | 82.33 |
Sherwin-williams Company, The | 32.69 | 32.69 | 4.16 | 11.44 | 0.7 | 0.1 | 0.01 | 14.68 |
Ecolab Inc. | 45.86 | 45.86 | 2.33 | 6.39 | 0.18 | 0.06 | 0.01 | 23.46 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Chemours Company, The | Buy | $4.0B | -28.91% | 10.03 | -3.95% |
Air Products & Chemicals Inc. | Buy | $52.2B | 17.58% | 22.41 | 18.82% |
Lyondellbasell Industries N.v. | Hold | $32.7B | 13.67% | 15.52 | 5.14% |
Linde Plc | Buy | $214.3B | 152.05% | 35.32 | 18.87% |
Sherwin-williams Company, The | Buy | $76.8B | 101.9% | 32.69 | 10.36% |
Ecolab Inc. | Hold | $62.8B | 20.39% | 45.86 | 8.96% |
BlackRock Inc
FMR Inc
Vanguard Group Inc
Bank of New York Mellon Corp
Massachusetts Financial Services Company
State Street Corporation
In the quarter ending March,2024. Chemours Company, The has declared dividend of $0.25
Read Morechemistry is a living thing. it’s constantly evolving and changing. the chemours company focuses on applying the power of chemistry to shape markets, redefine industries and change lives. chemours was created from dupont's performance chemicals businesses. we are a world leader in titanium technologies, fluoroproducts and chemical solutions. we're also a company of firsts, constantly changing the formula for what chemistry can do. consider these transformative product innovations: • ti-pure™ one coat technology and market understanding enables paint formulations that cover more, with less paint and less effort • opteon™ yf refrigerants for auto air conditioning systems have a global warming potential that is 99.9% lower than the current alternative, hfc-134a • teflon ecoelite™ finish, new to the market in 2016, is the first renewably sourced, non-fluorinated fabric treatment for durable water repellency; containing 60% renewably sourced raw material it repels water and water-based stai
Organization | Chemours Company, The |
Employees | 6200 |
CEO | Ms. Denise M. Dignam |
Industry | All Other Miscellaneous Chemical Product and Preparation Manufacturing |
Cerevel Therapeutics Holdings Inc
$27.08
+1.31%
Vaxcyte Inc
$27.08
+1.31%
Janux Therapeutics Inc
$27.08
+1.31%
Spdr Nuveen S&p High Yield Municipal Bond Etf
$27.08
+1.31%
Radnet Inc
$27.08
+1.31%
The St. Joe Co
$27.08
+1.31%
Harley-davidson, Inc.
$27.08
+1.31%
Vaneck Vectors Fallen Angel Hiyld Bd Etf
$27.08
+1.31%
Aurora Innovation Inc
$27.08
+1.31%